Physician profile
Breanna Nicole Wright
NPI 1710727847
$1,524.79
in general payments reported to CMS, 2019-2025
17 companies · $1,276 in 2025
The $1,276 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $249 · 2025: $1,276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,326 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.54 |
| Education | $199.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $255.87 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $241.59 | 2024-2025 | |
| Abbvie INC. | $217.71 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $202.45 | 2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $170.83 | 2025 | Nemluvio |
| Lilly USA, LLC | $140.86 | 2024-2025 | Taltz, Ebglyss |
| Sun Pharmaceutical Industries INC. | $83.86 | 2025 | |
| Incyte Corporation | $44.04 | 2024-2025 | Opzelura |
| Ucb, INC. | $27.36 | 2024-2025 | Bimzelx |
| Organon LLC | $22.97 | 2024-2025 | Hadlima |
| Genzyme Corporation | $19.28 | 2025 | |
| Leo Pharma INC. | $19.04 | 2025 | Adbry |
| Janssen Pharmaceuticals, INC | $17.78 | 2024 | Spravato |
| Pfizer INC. | $17.53 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.21 | 2025 | Spevigo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.31 | 2025 | Sotyktu |
| Verrica Pharmaceuticals INC. | $14.10 | 2024 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Breanna Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.